Pfizer To Provide New Zealand With 60,000 Treatment Courses Of Investigational Oral Antiviral Candidate
Monday, 6 December 2021, 3:52 pmPress Release: Pfizer If approved, PF-07321332 in combination with ritonavir would be the first oral antiviral of its kind,...

